Curcumin: Synthesis optimization and in silico interaction with cyclin dependent kinase.
Acta Pharmaceutica (Zagreb, Croatia)
|September 1, 2017
Summary
This study optimized curcumin synthesis for high yield and purity using ethyl acetate. Curcumin showed weak interactions with CDK4, suggesting limited therapeutic potential against certain cyclin-dependent kinases (CDKs).
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Computational Chemistry
Background:
- Curcumin, a natural product, possesses significant biological potential.
- Optimizing curcumin synthesis is crucial for its accessibility and application.
- Understanding curcumin's interaction with biological targets like cyclin-dependent kinases (CDKs) is key to exploring its therapeutic uses.
Purpose of the Study:
- To develop an optimal and rapid procedure for curcumin synthesis.
- To characterize and verify the purity of synthetic curcumin.
- To computationally evaluate curcumin's potential therapeutic interactions with CDK isoforms.
Main Methods:
- Curcumin synthesis using acetyl acetone, boron trioxide, vanillin, tri-n-butyl borate, and n-butylamine in ethyl acetate.
- Extraction of curcumin from turmeric powder.
- Spectroscopic analysis (IR, MS, 1H NMR, 13C NMR) and chromatographic purity assessment (TLC, HPLC-DAD).
- Molecular docking of curcumin against CDK2, CDK4, and CDK6.
Main Results:
- Ethyl acetate as a solvent significantly improved curcumin yield and purity.
- Spectroscopic and chromatographic methods confirmed the high purity of synthetic curcumin.
- Curcumin did not dock at the active sites of CDK2 and CDK6 but exhibited weak interactions with CDK4.
Conclusions:
- An efficient synthetic route for curcumin in ethyl acetate was established.
- The purity of synthetic curcumin was rigorously confirmed.
- Curcumin's limited interaction with CDK4 suggests a potential lack of efficacy against these specific targets, warranting further investigation for other therapeutic applications.
Related Concept Videos
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
02:15M-Cdk Drives Transition Into Mitosis
6.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
02:39Positive Regulator Molecules
7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
01:45Positive Regulator Molecules
136.7K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.7K
00:50Anaphase Promoting Complex
3.5K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
01:19Interactions Between Signaling Pathways
7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K